Stada offers option for fructose intolerance
This article was originally published in OTC Bulletin
Executive Summary
Stada Arzneimittel is offering a new OTC option to the 1 in 3 Germans it claims suffer from fructose malabsorption with the launch of its new fructose intolerance food supplement, Fructosin.